Plocabulin, a novel tubulin inhibitor, has potent antitumor activity in patient-derived xenograft models of gastrointestinal stromal tumors-Reference-Cited by-同舟云学术

Plocabulin, a novel tubulin inhibitor, has potent antitumor activity in patient-derived xenograft models of gastrointestinal stromal tumors

Published:2020-11 Issue:11 Volume:13 Page:100832
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Wang Yannick,Wozniak Agnieszka,Wellens Jasmien,Gebreyohannes Yemarshet K.,Guillén Maria Jose,Avilés Pablo M.,Debiec-Rychter Maria,Sciot Raf,Schöffski Patrick

Funder

PharmaMar

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference49 articles.

1. A gist of gastrointestinal stromal tumors: a review;Rammohan;World J Gastrointest Oncol.,2013

2. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas implications for surgical management and staging;Eng-Hen;Ann. Surg.,1992

3. Two hundred gastrointestinal stromal tumors;DeMatteo;Ann. Surg.,2000

4. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34;Sarlomo-Rikala;Mod. Pathol.,1998

5. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors;Hirota;Science,1998

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase I safety and efficacy clinical trial of plocabulin and gemcitabine in patients with advanced solid tumors;Investigational New Drugs;2024-08-03

2. An update on the development on tubulin inhibitors for the treatment of solid tumors;Expert Opinion on Therapeutic Targets;2024-03-03

3. Antitumor Efficacy of the Novel KIT Inhibitor IDRX-42 (Formerly M4205) in Patient- and Cell Line–Derived Xenograft Models of Gastrointestinal Stromal Tumor (GIST);Clinical Cancer Research;2023-05-24

4. Recent advances on marine mollusk-derived natural products: chemistry, chemical ecology and therapeutical potential;Natural Product Reports;2023

5. Effect of the Marine Polyketide Plocabulin on Tumor Progression;Marine Drugs;2022-12-31